Trials / Completed
CompletedNCT02835924
Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC
A Randomized Phase 2 Study Comparing Different Dose Approaches of Induction Treatment (First Cycle) of Regorafenib in Metastatic Colorectal Cancer (mCRC) Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 299 (actual)
- Sponsor
- Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and tolerability of different dose-escalation approaches of regorafenib in mCRC patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Regorafenib |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2018-09-01
- Completion
- 2019-09-01
- First posted
- 2016-07-18
- Last updated
- 2020-03-10
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02835924. Inclusion in this directory is not an endorsement.